These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32785219)

  • 1. Eight years of the East African Community Medicines Regulatory Harmonization initiative: Implementation, progress, and lessons learned.
    Mashingia JH; Ahonkhai V; Aineplan N; Ambali A; Angole A; Arik M; Azatyan S; Baak P; Bamenyekanye E; Bizoza A; Chamdimba C; Doerr P; Fimbo A; Gisagara A; Hamad H; Harris R; Hartman D; Kabatende J; Karangwa C; Kijo AS; Lumpkin M; Maboko S; Matle D; Muhairwe A; Mwesigye JP; Nyabenda B; Schulze A; Seiter A; Sematiko G; Sigonda M; Sillo H; Simai B; Siyoi F; Sonoiya S; Tanui P; Ward M; Yano F; Mukanga D
    PLoS Med; 2020 Aug; 17(8):e1003134. PubMed ID: 32785219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coming together to improve access to medicines: The genesis of the East African Community's Medicines Regulatory Harmonization initiative.
    Sillo H; Ambali A; Azatyan S; Chamdimba C; Kaale E; Kabatende J; Lumpkin M; Mashingia JH; Mukanga D; Nyabenda B; Sematiko G; Sigonda M; Simai B; Siyoi F; Sonoiya S; Ward M; Ahonkhai V
    PLoS Med; 2020 Aug; 17(8):e1003133. PubMed ID: 32785273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing the East African Community's Medicines Regulatory Harmonization initiative in 2020-2022: A Roadmap for the Future.
    Arik M; Bamenyekanye E; Fimbo A; Kabatende J; Kijo AS; Simai B; Siyoi F; Azatyan S; Ambali A; Cooke E; Mashingia JH; Mwesigye JP; Ndomondo-Sigonda M; Sillo H; Sonoiya S; Tanui P; Ward M; Delano T
    PLoS Med; 2020 Aug; 17(8):e1003129. PubMed ID: 32785229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new approach to an old problem: Overview of the East African Community's Medicines Regulatory Harmonization initiative.
    Ndomondo-Sigonda M; Mahlangu G; Agama-Anyetei M; Cooke E
    PLoS Med; 2020 Aug; 17(8):e1003099. PubMed ID: 32785223
    [No Abstract]   [Full Text] [Related]  

  • 5. Improving access to quality medicines in East Africa: An independent perspective on the East African Community Medicines Regulatory Harmonization initiative.
    Giaquinto AR; Grignolo A; Liberti L; Lim JCW; Salmonson T; Sauer F; Ukwu H
    PLoS Med; 2020 Aug; 17(8):e1003092. PubMed ID: 32785224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Industrial perceptions of medicines regulatory harmonization in the East African Community.
    Dansie LS; Odoch WD; Årdal C
    PLoS One; 2019; 14(6):e0218617. PubMed ID: 31216323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future of the European Union regulatory network in the context of the uptake of new medicines.
    Hoebert JM; Irs A; Mantel-Teeuwisse AK; Leufkens HG
    Br J Clin Pharmacol; 2013 Jul; 76(1):1-6. PubMed ID: 23043328
    [No Abstract]   [Full Text] [Related]  

  • 8. False hope with the Right to Try Act.
    The Lancet
    Lancet; 2018 Jun; 391(10137):2296. PubMed ID: 29900858
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent developments in health law.
    Lee WB; Shachar C; Chang P
    J Law Med Ethics; 2008; 36(1):191-9. PubMed ID: 18315772
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulatory performance of the East African Community joint assessment procedure: The way forward for regulatory systems strengthening.
    Mashingia J; Ngum N; Ndomondo-Sigonda M; Kermad A; Bujar M; Salek S; Walker S
    Regul Toxicol Pharmacol; 2023 May; 140():105383. PubMed ID: 36933643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right to try?
    Lieu CH; Sorkin A; Messersmith WA
    J Clin Oncol; 2015 May; 33(13):1518. PubMed ID: 25779561
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulatory watch: Innovative drug availability in China.
    Shao L; Xu L; Li Q; Chakravarthy R; Yang Z; Kaitin KI
    Nat Rev Drug Discov; 2016 Nov; 15(11):739-740. PubMed ID: 27765941
    [No Abstract]   [Full Text] [Related]  

  • 13. Access to drugs: the case of Abbott in Thailand.
    Cawthorne P; Ford N; Wilson D; Kijtiwatchakul K; Purahong V; Tianudom N; Nacapew S
    Lancet Infect Dis; 2007 Jun; 7(6):373-4. PubMed ID: 17521589
    [No Abstract]   [Full Text] [Related]  

  • 14. Time to Reevaluate U.S. Mifepristone Restrictions.
    Henney JE; Gayle HD
    N Engl J Med; 2019 Aug; 381(7):597-598. PubMed ID: 31242357
    [No Abstract]   [Full Text] [Related]  

  • 15. Increasing Use of Compassionate Use/Managed Access Channels to Obtain Medicines for Use in COVID-19.
    Aliu P; Sarp S; Fitzsimmons P
    Clin Pharmacol Ther; 2021 Jul; 110(1):26-28. PubMed ID: 33326600
    [No Abstract]   [Full Text] [Related]  

  • 16. Putting patients first in medicines regulation?
    Naci H; Forrest R; Davis C
    BMJ; 2021 Nov; 375():n2883. PubMed ID: 34848394
    [No Abstract]   [Full Text] [Related]  

  • 17. Walking the drug regulatory tightrope.
    Dove A
    Nat Biotechnol; 2003 May; 21(5):495-8. PubMed ID: 12721571
    [No Abstract]   [Full Text] [Related]  

  • 18. The Garden State just got greener: New Jersey is the fourteenth state in the nation to legalize medical marijuana.
    Brown M
    Seton Hall Law Rev; 2011; 41(4):1519-67. PubMed ID: 22368811
    [No Abstract]   [Full Text] [Related]  

  • 19. Complementary medicines: When regulation results in revolution.
    Fourie L; Oosthuizen F; Du Toit K
    S Afr Med J; 2017 May; 107(6):483-485. PubMed ID: 28604318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The African medicines regulatory harmonization initiative: rationale and benefits.
    Ndomondo-Sigonda M; Ambali A
    Clin Pharmacol Ther; 2011 Feb; 89(2):176-8. PubMed ID: 21252936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.